atcogliflozin25mg30tab

Atcogliflozin is a pharmaceutical product containing Empagliflozin, which belongs to the class of Sodium-Glucose Co-transporter 2 (SGLT2) inhibitors. It is primarily indicated for the management of type 2 diabetes mellitus in adults. By inhibiting the SGLT2 protein in the kidneys, it reduces the reabsorption of glucose, thereby promoting the excretion of excess sugar through urine. This mechanism helps in improving glycemic control and may also provide cardiovascular benefits. It is intended for use as an adjunct to diet and exercise to improve blood sugar levels in patients with type 2 diabetes.